Agenus Inc. ( AGEN) - Stock Earnings

AGEN Quarterly earnings

Analyst consensus estimates are available to paid members.

DateEarningsRevenue
2025Q4 -10.6 million USD 34.2 million USD
2026Q1 39.2 million USD 33.7 million USD
2026Q2 -550000 USD 34.5 million USD
2026Q3 Est.
2026Q4 Est.
2027Q1 Est.

AGEN Yearly earnings

Analyst consensus estimates are available to paid members.

DateEarningsRevenue
2023 -245.8 million USD 156.3 million USD
2024 -227.2 million USD 103.5 million USD
2025 115000 USD 114.2 million USD
2026 Est.

AGEN

Price: $7.13

52 week price:
2.71
8.85

Payout Ratio Range:
-49814.29%
2920.16%

Earnings Per Share: 2.99 USD

P/E Ratio: 2.45

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 207310

Ebitda: -30.2 million

Market Capitalization: 329.5 million

Links: